List of Excipients in API LAMIVUDINE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing LAMIVUDINE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| GlaxoSmithKline LLC | EPIVIR | lamivudine | 0173-0662 | CELLULOSE, MICROCRYSTALLINE | |
| GlaxoSmithKline LLC | EPIVIR | lamivudine | 0173-0662 | FERRIC OXIDE RED | |
| GlaxoSmithKline LLC | EPIVIR | lamivudine | 0173-0662 | FERRIC OXIDE YELLOW | |
| GlaxoSmithKline LLC | EPIVIR | lamivudine | 0173-0662 | HYPROMELLOSE | |
| GlaxoSmithKline LLC | EPIVIR | lamivudine | 0173-0662 | MAGNESIUM STEARATE | |
| GlaxoSmithKline LLC | EPIVIR | lamivudine | 0173-0662 | POLYETHYLENE GLYCOL | |
| GlaxoSmithKline LLC | EPIVIR | lamivudine | 0173-0662 | POLYSORBATE 80 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing LAMIVUDINE
Detailed excipient profiles for LAMIVUDINE
Excipient focus: ALCOHOL
LAMIVUDINE drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | lamivudine | 10135-605 |
| Lannett Company Inc | lamivudine | 54838-566 |
| Chartwell RX LLC | lamivudine oral | 62135-706 |
| >Company | >Ingredient | >NDC |
LAMIVUDINE drug variants not containing ALCOHOL
Excipient focus: ANHYDROUS CITRIC ACID
LAMIVUDINE drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | lamivudine | 10135-605 |
| Lannett Company Inc | lamivudine | 54838-566 |
| Rising Pharma Holdings Inc | lamivudine | 57237-274 |
| Aurobindo Pharma Limited | lamivudine | 65862-055 |
| Chartwell RX LLC | lamivudine oral | 62135-706 |
| >Company | >Ingredient | >NDC |
LAMIVUDINE drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: ANHYDROUS LACTOSE
LAMIVUDINE drug variants containing ANHYDROUS LACTOSE
LAMIVUDINE drug variants not containing ANHYDROUS LACTOSE
Excipient focus: BANANA
LAMIVUDINE drug variants containing BANANA
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | lamivudine | 57237-274 |
| Aurobindo Pharma Limited | lamivudine | 65862-055 |
| >Company | >Ingredient | >NDC |
LAMIVUDINE drug variants not containing BANANA
Excipient focus: CELLULOSE, MICROCRYSTALLINE
LAMIVUDINE drug variants containing CELLULOSE, MICROCRYSTALLINE
LAMIVUDINE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: COLLOIDAL SILICON DIOXIDE
LAMIVUDINE drug variants containing COLLOIDAL SILICON DIOXIDE
LAMIVUDINE drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSCARMELLOSE SODIUM
LAMIVUDINE drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Viatris Specialty LLC | lamivudine and tenofovir disoproxil fumarate | 49502-450 |
| CELLTRION USA INC | lamivudine and tenofovir disoproxil fumarate | 72606-002 |
| >Company | >Ingredient | >NDC |
LAMIVUDINE drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
LAMIVUDINE drug variants containing CROSPOVIDONE
LAMIVUDINE drug variants not containing CROSPOVIDONE
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
LAMIVUDINE drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| LUPIN LIMITED | lamivudine and zidovudine | 57297-284 |
| Lupin Pharmaceuticals Inc | lamivudine and zidovudine | 68180-284 |
| >Company | >Ingredient | >NDC |
LAMIVUDINE drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Excipient focus: EDETATE DISODIUM
LAMIVUDINE drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | lamivudine | 10135-605 |
| Lannett Company Inc | lamivudine | 54838-566 |
| Chartwell RX LLC | lamivudine oral | 62135-706 |
| >Company | >Ingredient | >NDC |
LAMIVUDINE drug variants not containing EDETATE DISODIUM
Excipient focus: FERRIC OXIDE RED
LAMIVUDINE drug variants containing FERRIC OXIDE RED
LAMIVUDINE drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
LAMIVUDINE drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | lamivudine | 0173-0662 |
| Camber Pharmaceuticals Inc | lamivudine | 31722-752 |
| Golden State Medical Supply Inc | lamivudine | 51407-866 |
| State of Florida DOH Central Pharmacy | lamivudine | 53808-0893 |
| Apotex Corp | lamivudine | 60505-3250 |
| Prasco Laboratories | lamivudine | 66993-478 |
| >Company | >Ingredient | >NDC |
LAMIVUDINE drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: HYDROXYPROPYL CELLULOSE
LAMIVUDINE drug variants containing HYDROXYPROPYL CELLULOSE
LAMIVUDINE drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
LAMIVUDINE drug variants containing HYPROMELLOSE
LAMIVUDINE drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
LAMIVUDINE drug variants containing HYPROMELLOSE 2910
LAMIVUDINE drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
LAMIVUDINE drug variants containing HYPROMELLOSES
LAMIVUDINE drug variants not containing HYPROMELLOSES
Excipient focus: ISOMALT
LAMIVUDINE drug variants containing ISOMALT
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | lamivudine | 31722-752 |
| Camber Pharmaceuticals Inc | lamivudine | 31722-753 |
| AvPAK | lamivudine | 50268-459 |
| >Company | >Ingredient | >NDC |
LAMIVUDINE drug variants not containing ISOMALT
Excipient focus: ISOPROPYL ALCOHOL
LAMIVUDINE drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | lamivudine | 31722-752 |
| Camber Pharmaceuticals Inc | lamivudine | 31722-753 |
| AvPAK | lamivudine | 50268-459 |
| >Company | >Ingredient | >NDC |
LAMIVUDINE drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE MONOHYDRATE
LAMIVUDINE drug variants containing LACTOSE MONOHYDRATE
LAMIVUDINE drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
LAMIVUDINE drug variants containing MAGNESIUM STEARATE
LAMIVUDINE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | lamivudine | 10135-605 |
| Lannett Company Inc | lamivudine | 54838-566 |
| Rising Pharma Holdings Inc | lamivudine | 57237-274 |
| Aurobindo Pharma Limited | lamivudine | 65862-055 |
| Chartwell RX LLC | lamivudine oral | 62135-706 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLENE CHLORIDE
LAMIVUDINE drug variants containing METHYLENE CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | lamivudine | 31722-752 |
| Camber Pharmaceuticals Inc | lamivudine | 31722-753 |
| AvPAK | lamivudine | 50268-459 |
| >Company | >Ingredient | >NDC |
LAMIVUDINE drug variants not containing METHYLENE CHLORIDE
Excipient focus: METHYLPARABEN
LAMIVUDINE drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | lamivudine | 10135-605 |
| Lannett Company Inc | lamivudine | 54838-566 |
| Rising Pharma Holdings Inc | lamivudine | 57237-274 |
| Aurobindo Pharma Limited | lamivudine | 65862-055 |
| Chartwell RX LLC | lamivudine oral | 62135-706 |
| >Company | >Ingredient | >NDC |
LAMIVUDINE drug variants not containing METHYLPARABEN
Excipient focus: POLYETHYLENE GLYCOL
LAMIVUDINE drug variants containing POLYETHYLENE GLYCOL
LAMIVUDINE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
LAMIVUDINE drug variants containing POLYETHYLENE GLYCOL 400
LAMIVUDINE drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 6000
LAMIVUDINE drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | lamivudine | 69097-166 |
| >Company | >Ingredient | >NDC |
LAMIVUDINE drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYETHYLENE GLYCOL 8000
LAMIVUDINE drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | lamivudine | 0904-6583 |
| Golden State Medical Supply Inc | lamivudine | 51407-866 |
| Golden State Medical Supply Inc | lamivudine | 60429-353 |
| Apotex Corp | lamivudine | 60505-3250 |
| Apotex Corp | lamivudine | 60505-3251 |
| American Health Packaging | lamivudine | 60687-720 |
| >Company | >Ingredient | >NDC |
LAMIVUDINE drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYETHYLENE GLYCOLS
LAMIVUDINE drug variants containing POLYETHYLENE GLYCOLS
LAMIVUDINE drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYSORBATE 80
LAMIVUDINE drug variants containing POLYSORBATE 80
LAMIVUDINE drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ALCOHOL
LAMIVUDINE drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Viatris Specialty LLC | lamivudine and tenofovir disoproxil fumarate | 49502-450 |
| >Company | >Ingredient | >NDC |
LAMIVUDINE drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE
LAMIVUDINE drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | lamivudine | 68180-602 |
| LUPIN LIMITED | lamivudine and zidovudine | 57297-284 |
| Lupin Pharmaceuticals Inc | lamivudine and zidovudine | 68180-284 |
| >Company | >Ingredient | >NDC |
LAMIVUDINE drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
LAMIVUDINE drug variants containing POVIDONE K30
LAMIVUDINE drug variants not containing POVIDONE K30
Excipient focus: POWDERED CELLULOSE
LAMIVUDINE drug variants containing POWDERED CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| CELLTRION USA INC | lamivudine and tenofovir disoproxil fumarate | 72606-002 |
| >Company | >Ingredient | >NDC |
LAMIVUDINE drug variants not containing POWDERED CELLULOSE
Excipient focus: PROPYLENE GLYCOL
LAMIVUDINE drug variants containing PROPYLENE GLYCOL
LAMIVUDINE drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
LAMIVUDINE drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | lamivudine | 10135-605 |
| Lannett Company Inc | lamivudine | 54838-566 |
| Rising Pharma Holdings Inc | lamivudine | 57237-274 |
| Aurobindo Pharma Limited | lamivudine | 65862-055 |
| Chartwell RX LLC | lamivudine oral | 62135-706 |
| >Company | >Ingredient | >NDC |
LAMIVUDINE drug variants not containing PROPYLPARABEN
Excipient focus: SILICON DIOXIDE
LAMIVUDINE drug variants containing SILICON DIOXIDE
LAMIVUDINE drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM CITRATE
LAMIVUDINE drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | lamivudine | 10135-605 |
| Lannett Company Inc | lamivudine | 54838-566 |
| Chartwell RX LLC | lamivudine oral | 62135-706 |
| >Company | >Ingredient | >NDC |
LAMIVUDINE drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
LAMIVUDINE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
LAMIVUDINE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SODIUM STARCH GLYCOLATE TYPE B POTATO
LAMIVUDINE drug variants containing SODIUM STARCH GLYCOLATE TYPE B POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | lamivudine | 69097-166 |
| >Company | >Ingredient | >NDC |
LAMIVUDINE drug variants not containing SODIUM STARCH GLYCOLATE TYPE B POTATO
Excipient focus: STARCH, CORN
LAMIVUDINE drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | lamivudine | 69097-166 |
| >Company | >Ingredient | >NDC |
LAMIVUDINE drug variants not containing STARCH, CORN
Excipient focus: STRAWBERRY
LAMIVUDINE drug variants containing STRAWBERRY
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | lamivudine | 57237-274 |
| Aurobindo Pharma Limited | lamivudine | 65862-055 |
| >Company | >Ingredient | >NDC |
LAMIVUDINE drug variants not containing STRAWBERRY
Excipient focus: SUCROSE
LAMIVUDINE drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | lamivudine | 10135-605 |
| Lannett Company Inc | lamivudine | 54838-566 |
| Rising Pharma Holdings Inc | lamivudine | 57237-274 |
| Aurobindo Pharma Limited | lamivudine | 65862-055 |
| Chartwell RX LLC | lamivudine oral | 62135-706 |
| >Company | >Ingredient | >NDC |
LAMIVUDINE drug variants not containing SUCROSE
Excipient focus: TALC
LAMIVUDINE drug variants containing TALC
LAMIVUDINE drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
LAMIVUDINE drug variants containing TITANIUM DIOXIDE
LAMIVUDINE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | lamivudine | 10135-605 |
| Lannett Company Inc | lamivudine | 54838-566 |
| Rising Pharma Holdings Inc | lamivudine | 57237-274 |
| Aurobindo Pharma Limited | lamivudine | 65862-055 |
| Chartwell RX LLC | lamivudine oral | 62135-706 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
LAMIVUDINE drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | lamivudine | 57237-274 |
| Aurobindo Pharma Limited | lamivudine | 65862-055 |
| >Company | >Ingredient | >NDC |
LAMIVUDINE drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
LAMIVUDINE drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | lamivudine | 10135-605 |
| Lannett Company Inc | lamivudine | 54838-566 |
| Centaur Pharmaceuticals Private Limited | lamivudine | 64330-001 |
| Chartwell RX LLC | lamivudine oral | 62135-706 |
| >Company | >Ingredient | >NDC |
LAMIVUDINE drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
